Mona Ridderheim (Former)

1 – 10 of 16

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/med-mri?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
next »

2012
Mark First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
Lindemann, K. ; Christensen, R. D. ; Vergote, I. ; Stuart, G. ; Izquierdo, M. A. ; Kaem, J. ; Havsteen, H. ; Eisenhauer, E. ; Ridderheim, Mona ^LU and Lopez, A. B. , et al. (2012) In Annals of Oncology 23(10). p.31-2613
- Contribution to journal › Article
2007
Mark FDG-PET in cervical cancer: staging, re-staging and follow-up.
Bjurberg, Maria ^LU ; Kjellén, Elisabeth ^LU ; Ohlsson, Tomas G ^LU ; Ridderheim, Mona ^LU and Brun, Eva ^LU (2007) In Acta Obstetricia et Gynecologica Scandinavica 86(11). p.1385-1391
- Contribution to journal › Article
2006
Mark The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
Malander, Susanne ^LU ; Rambech, Eva ^LU ; Kristoffersson, Ulf ^LU ; Halvarsson, Britta ^LU ; Ridderheim, Mona ^LU ; Borg, Åke ^LU and Nilbert, Mef ^LU (2006) In Gynecologic Oncology 101(2). p.238-243
- Contribution to journal › Article
2005
Mark Sequential topotecan and oral etoposide in recurrent ovarian carcinoma pretreated with platinum-taxane - Results from a multicenter phase I/II study
Gronlund, B ; Engelholm, SA ; Horvath, G ; Maenpaa, J and Ridderheim, Mona ^LU (2005) In Cancer 103(7). p.1388-1396
- Contribution to journal › Article
Mark The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers
Johansson, B ; Ridderheim, Mona ^LU and Glimelius, B (2005) In Acta Oncologica 44(8). p.890-895
- Contribution to journal › Article
2004
Mark One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
Malander, S ^LU ; Ridderheim, M ^LU ; Måsbäck, A ^LU ; Loman, N ^LU ; Kristoffersson, U ^LU ; Olsson, Håkan ^LU ; Nilbert, M ^LU and Borg, Åke ^LU (2004) In European Journal of Cancer 40(3). p.422-428
- Contribution to journal › Article
2003
Mark First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
Kristensen, GB ; Vergote, I ; Stuart, G ; Del Campo, JM ; Kaern, J ; Lopez, AB ; Eisenhauer, E ; Aavall-Lundquist, E ; Ridderheim, Mona ^LU and Havsteen, H , et al. (2003) In International Journal of Gynecological Cancer 13. p.172-177
- Contribution to journal › Article
Mark A systematic overview of radiation therapy effects in ovarian cancer
Einhorn, N ; Trope, C ; Ridderheim, Mona ^LU ; Boman, K ; Sorbe, B and Cavallin-Ståhl, Eva ^LU (2003) In Acta Oncologica 42(5-6). p.562-566
- Contribution to journal › Article
Mark A systematic overview of radiation therapy effects in uterine cancer (corpus uteri)
Einhorn, N ; Trope, C ; Ridderheim, Mona ^LU ; Boman, K ; Sorbe, B and Cavallin-Ståhl, Eva ^LU (2003) In Acta Oncologica 42(5-6). p.557-561
- Contribution to journal › Article
Mark A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)
Einhorn, N ; Trope, C ; Ridderheim, Mona ^LU ; Boman, K ; Sorbe, B and Cavallin-Ståhl, Eva ^LU (2003) In Acta Oncologica 42(5-6). p.546-556
- Contribution to journal › Article

« previous
1
2
next »